Psygen
A Dedicated Psychedelic GMP Manufacturer
A Dedicated Psychedelic GMP Manufacturer
Psygen is a biotechnology and manufacturing startup founded in 2019 and based in Canada. The company's slogan, "A Dedicated Psychedelic GMP Manufacturer," underscores its primary focus on providing a pharmaceutical-grade psychedelic supply chain solution for clinicians and researchers. Psygen boasts the world's first dedicated, GMP compliant, state-of-the-art, large-scale manufacturing facility, positioning itself as a leader in this niche market. Their most recent investment, a Venture Round investment at 01 January 2022, came from Noetic Fund. This strategic investment signifies confidence in Psygen's innovative approach and potential for growth within the burgeoning psychedelic medicine industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 1 |
|
01 Jan 2022 |
| Debt Financing | $5.50M | - | 05 Aug 2021 |
No recent news or press coverage available for Psygen.
We care about your data, and we'd love to use cookies make your experience better.
